Oct 16, 2018 Optimal stroke prevention in patients with patent foramen ovale Optimal stroke prevention in patients with patent foramen ovaleIn The Lancet Neurology, Scott E Kasner and colleagues report the results of a subgroup analysis of the NAVIGATE ESUS trial comparing rivaroxaban ... read morePublished on 2018-10-16